CS Paper Radar

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu

cs.AI cs.HC ·submitted 2026-08-31 07:41 UTC · v1

Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

Closest papers

Nearest neighbours by meaning across the whole index.

CareGraph: An Auditable Hybrid AI Framework for Evidence-Grounded Personalized Longitudinal Health Intelligence

cs.AI cs.IRcs.MA ·2026-08-25 ·Pratik Ghawate, Tanvi Patil
benchmarkcode/data similarity 0.72
Abstract · 21 pages, 7 figures, Code and data: https://github.com/PratikGhawate/ai-personalized-health-intelligence

Artificial intelligence is transforming personalized healthcare, yet fragmented clinical, self reported, and wearable evidence remains difficult to interpret and trace. We present CareGraph, an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations. CareGraph organizes evidence without diagnosing, predicting outcomes, selecting treatment, or making autonomous clinical decisions. Its pipeline covers deterministic analysis, context detection, graph construction, constrained language model synthesis, evidence validation, safety controls, and release gating. Tests used synthetic cohorts of 400 patients each for development, validation, and holdout. On holdout data, a frozen ordinary least squares trend rule with a sufficiency gate achieved 0.827 accuracy, 0.837 macro F1 with a 95 percent confidence interval of 0.819 to 0.854, and 0.974 insufficient data F1. Missing context detection achieved 0.815 strict micro F1 versus 0.318 for the legacy detector. On an authored holdout benchmark, safety ruleset version 1.2 achieved 1.000 precision, 0.950 recall, and 0.974 F1. An audit requiring graph retrieval across 80 patients yielded 79 syntheses and 78 presentations without fallback; one output was blocked and one failed closed because of an invalid evidence key. Against monolithic GPT 5.6 on 56 matched patients, CareGraph was faster at 40.15 versus 49.62 seconds, shorter at 661 versus 1,163 words, and showed better exploratory lexical alignment with longitudinal targets; the baseline used fewer tokens and cited more raw evidence. Graph auditing verified provenance and deterministic retrieval; incremental graph effects on generation require paired evaluation. CareGraph offers a safety bounded foundation for intelligent personalized health systems.

0.42

Right Diagnosis, Unsafe Route: Auditing Clinical AI Decision Trajectories and Corrective Oversight for Validity and Potential Harm

cs.AI ·2026-11-17 ·Guanqiao Chen, Wei Jiang, Shu Zhang, Qian Lin, Guanxu Yu +3 more
benchmarkcode/data similarity 0.71
Abstract

A clinical AI system can reach a correct final diagnosis through intermediate decisions that could have harmed the patient, and can repair an error while introducing new risks. Most evaluations score final diagnoses; even stepwise benchmarks, which release a case's evidence over time, score whether systems reach the right diagnosis or gather the right information, not whether the decisions a patient passes through are safe. We make patient safety the target of stepwise evaluation. A trajectory audit replays real admissions checkpoint by checkpoint, lets each system decide with only the evidence released so far, and rates every test, treatment and disposition for its potential harm to the patient and, separately, for clinical validity, against the documented final diagnosis and physician-written disease rubrics yet on the evidence available when the decision was made. An LLM judge scores every decision, and a physician reference standard (triple annotation and senior adjudication of a stratified sample) calibrates the rates. An oversight audit branches each trajectory at its first actionable error and measures, on the same branches, whether corrective feedback repairs the error and whether it introduces new harm. Across 300 cases from a hospital cardiology cohort, MIMIC-IV and the public ASCENT benchmark, with up to seven AI systems per source, 55.2% of hospital trajectories reaching an acceptable final diagnosis passed through a decision with moderate or severe potential harm and 24.8% through a clinically unacceptable one; the harm rates were 76.2% on MIMIC-IV and 39.6% on ASCENT. Structured corrections resolved 73.6% of first errors versus 24.8% after bare rejection, yet new potentially unsafe decisions followed 30.2% of corrections versus 19.7% of rejections. A correct final diagnosis does not certify a safe trajectory, and a successful correction does not certify a safe recovery.

0.36

Constructing and Evaluating Clinical Reasoning Trajectories for Medical Agent

cs.AI ·2026-09-04 ·Yunqi Zhu, Wen Tang, Jinghao Niu, Wensheng Zhang, Xuebing Yang
similarity 0.69
Abstract

Evaluation of medical artificial intelligence (AI) agents remains predominantly answer-centric, assessing only the correctness of final outputs while overlooking the quality of intermediate reasoning. We propose MedTraj, a framework that treats reasoning trajectories as primary objects for modeling the progressive refinement of clinical evidence toward diagnostic decisions. A reasoning trajectory captures the state transitions among medical concepts---from clinical observations through evidential reasoning to a final conclusion---making the implicit reasoning chain of a medical agent explicit and inspectable. Each trajectory is scored across five quality dimensions: coherence, evidence support, hallucination, completeness, and traceability. Controlled error injection introduces targeted faults into otherwise correct trajectories to establish causal links between specific reasoning failures and measurable quality degradation. Step-level filtering based on marginal contribution identifies which individual reasoning steps drive or undermine reasoning trajectory quality. Quality-weighted reasoning trajectory context feeds these evaluations back into the model at inference time. Experiments across CareQA, PubMedQA, and CECMed demonstrate that reasoning trajectory context consistently improves reasoning coherence. For the severity assessment on the CECMed, quality-weighted reasoning trajectory context nearly doubles the correctness over the zero-shot baseline while cutting the hallucination ratio by 87%. Experiments show that 15.3% of reasoning steps carry most of the quality signal, and that extending chains beyond four steps yields diminishing returns.

0.13

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

cs.AI ·2026-11-17 ·Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko +8 more
similarity 0.69
Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

0.25

Auditing Escalation Reliability in Healthcare LLM Agents: A Perturbation-Controlled Benchmark of Workflow-State Failures

cs.AI cs.CL ·2026-10-15 ·Zihao Zheng, Junyi Yao, Baichuan Li, Jiayu Long
benchmark similarity 0.66
Abstract · 8 pages, 5 figures

Trustworthy biomedical AI requires reliable action selection when evidence is missing, stale, conflicting, or late, not only accurate answers on static inputs. We instantiate an episode-level evaluation protocol as 400 synthetic healthcare workflow episodes: 40 hand-authored semantic seeds across four task classes, two surface parameterizations, and five controlled variants, scored on ANSWER/ASK CLARIFICATION/ABSTAIN/ESCALATE under a pre-declared 5:1 missed-versus-unnecessary escalation cost. Reference actions are single-author study-policy labels, not clinician-adjudicated ground truth. Across five open-weight configurations (1.7B--9.7B), clean decision accuracy reaches 0.97, yet uncertainty-prompted models miss 32--97% of required escalations. The stronger 9.7B configuration narrows but does not remove the gap, falling from 0.97 clean accuracy to 0.78 under conflict. Verbalized confidence is inconsistent (ECE 0.10--0.54; failure AUROC 0.48--0.77), and a development-tuned confidence-only policy yields no utility gain. A transparent workflow-aware controller improves 5:1 utility for every model and reduces missed escalations to 0.12--0.24, at specificity 0.83--0.93. However, a 30-concept lexical stress test reduces each rule detector's recall from 1.00 on trigger phrases to 0.00 on unseen paraphrases, limiting the controller claim to this benchmark. Seed-clustered statistics, ablations, cross-task transfer, raw outputs, and manifests are packaged for audit. The results motivate explicit workflow-state evaluation while showing that apparently effective routing controls need their own generalization tests.

0.46

Examining the Vulnerability of Multi-Agent Medical Systems to Human Interventions for Clinical Reasoning

cs.AI ·2026-09-02 ·Benjamin C Liu, Dillon Mehta, Rishi Malhotra, Adam Zobian, Yong Ying Tan +5 more
similarity 0.65
Abstract

Human interventions at fault points can alter the diagnostic accuracy of multi-agent medical systems. We defined fault points as moments in AI agent conversations, in which an agent's reasoning became most vulnerable to external influence. Using the MedQA dataset, this study analyzed simulated doctor-patient conversations to measure how interventions shifted reasoning and accuracy. Correct intervention methods showed an improvement in baseline diagnostic accuracy of up to 40%, while incorrect or bias-related interventions degraded performance by up to 6% and increased diagnostic drift and uncertainty. Beyond performance changes, our analysis revealed behavioral similarities between cognitive biases in simulated agent environments and real-world clinical practice. Examples included premature closure and susceptibility to misleading cues. Overall, these findings demonstrate that identifying and guiding fault points with human interventions may provide a mechanism for improving diagnostic robustness in multi-agent medical systems.

0.28

Complementary Vulnerabilities: Auditing and Governing Clinician-LLM Error Overlap

cs.CY ·2026-10-18 ·Mohsen Amoei, Kathleen Fraser, Dan Poenaru
published similarity 0.64
Abstract · 4 pages main text, 2 figures. Accepted at SMASH 2026, the Symposium on Model Accountability, Sustainability and Healthcare (Mila, Montreal, …

Health systems are deploying large language models (LLMs) into clinical workflows, often on the assumption that a second automated check can only reduce error. But a second reasoner reduces error only insofar as it fails differently from the first. We say that a clinician and a model have complementary vulnerabilities to the extent that they break down through different mechanisms and on different cases. The two reasoners' failure substrates differ: they are embodied and cognitive in the clinician, and statistical and generative in the model - so their weak points need not line up. That divergence is plausible rather than guaranteed, and the independence it creates is fragile, eroding when clinicians defer to the model or the model conforms to the clinician. We therefore propose a predeployment audit in which each site measures error overlap on its own cases. We also propose a governance model with which the site keeps those errors independent over time. Health systems should then judge a clinical artificial intelligence (AI) tool by whether its failures overlap with their clinicians' failures, as well as by its accuracy.

0.37

Asclepius: An Adaptive Harness for Long-Horizon Clinical Agents

cs.AI ·2026-09-11 ·Grace Chang Yuan, Xiaoman Zhang, Sung Eun Kim, Luyang Luo, Pranav Rajpurkar
top venue similarity 0.63
Abstract · 9 pages, 4 figures, 11 tables. EMNLP 2026 Findings

LLM agents are predominantly benchmarked on short, single-task trajectories, yet real deployments run for hours under contention, surfacing a different class of failures. We use the Clinical Environment Simulator (CES), in which an agent manages an entire emergency-department shift under continuous time and resource pressure, as a testbed: long-horizon execution failures manifest measurably in a single rollout under structured, multi-dimensional grading. On CES, current agents reach the correct diagnosis in most cases yet fail to deliver complete and timely critical actions, revealing an execution gap. We attribute this gap to three long-horizon failure modes, each operationalized as a per-trace counter: instruction-adherence drift, treatment incompleteness, and a severity-equity gap in timeliness. We then introduce Asclepius, an adaptive agent scaffolding with a self-evolving harness that rewrites the operating manual between shifts from trace-level feedback, an externalized clinical skills library for high-stakes regimen knowledge, and three isolated subagents that partition per-turn decisions across the patient queue. On held-out batches never observed during harness evolution, Asclepius improves critical-action correctness by 22% (p = 0.024) over a strong baseline agent framework while preserving diagnostic accuracy, with consistent gains across five LLM judges from three model families; on the full ten-batch set, improvements reach 25% on critical actions and 13% on timeliness. The three failure modes form a coupled bottleneck: decisive reductions appear only when all three components act together.

0.64